IMT-2020-0325.docx (22.07 kB)

Supplementary Files – Potential biomarkers and resistance mechanisms of atezolizumab in a patient with lung squamous cell carcinoma

dataset

posted on 2021-11-12, 09:20 authored by Kangqi Ren, Quanzhou Peng, Yefeng Yu, Guanggui Ding, Tonghai Huang, Tao Yu, Lin Yanga

Supplementary Material: Potential biomarkers and resistance mechanisms of atezolizumab in a patient with lung squamous cell carcinoma

Supplementary Methods Details

History

Usage metrics

Read the peer-reviewed publication

Potential biomarkers and resistance mechanisms of atezolizumab in a patient with lung squamous cell carcinoma

Categories

Keywords

non-small cell lung cancer atezolizumab immunotherapy tumor microenvironment Tumour Immunology Cancer Therapy (excl. Chemotherapy and Radiation Therapy)Molecular Targets Cancer Cell Biology

Licence

CC BY-NC-ND 4.0

Exports